A critical incident declared at Nottingham University Hospitals NHS Trust (NUH) is not the result of a cyber attack, the trust has told Digital Health News.
NUH declared a critical incident on 10 September 2024,…
Meet Dr. Hekmieh Manad, Malaffi's TOP users for 2023! As an esteemed Internal Medicine Specialist at #Mediclinic's Al Mamora Branch, Dr Hekmieh shares one of a compelling story from her clinical practice, highlighting how…
Continue Reading
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading
What You Should Know:
– Karius®, a leader in genomic diagnostics for infectious disease, announced today the closing of a $100 million Series C funding round.
– Co-led by Khosla Ventures and newcomers 5AM Ventures and…
Continue Reading
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.These include a project that will establish a patient dataset of inherited retinal…
Continue Reading
Upfront Diagnostics has been crowned the first-ever champion in the pre-revenue generating category of Digital Health Rewired Pitchfest 2024.Its solution is a blood test for large vessel occlusion stroke diagnosis called “LVOne”, enabling a…
Continue Reading
What You Should Know:
– Neurocode USA, Inc., a provider of neurological testing, has announced the launch of ALZpath Dx, a novel blood test for Alzheimer’s disease (AD) in the United States.
– The availability of…
Continue Reading
LloydsPharmacy is enhancing its sexual health testing services, with a newly announced partnership with Preventx, a leading diagnostic provider.The collaboration will boost LloydsPharmacy Online Doctor’s testing services for sexual health – which include test…
Continue Reading
A new pancreatic cancer prediction model, utilizing routine blood markers, may reduce unnecessary biopsies by up to 6%. Researchers have validated this model, which assesses early-stage pancreatic cancer risk, and found it outperforms individual…
Continue Reading
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.Hikma Pharmaceuticals’ venture capital arm, Hikma Ventures, participated…
Continue Reading
